Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Cognitive Impairment in Schizophrenia
NCT00743847Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Mar 2009
- Primary completion
- Nov 2009
01
Overview
A Phase 2 trial of varenicline in schizophrenia, sponsored by Pfizer. Planned start Mar 2009; status: withdrawn.
02
Drugs
varenicline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00743847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743847.